CEO and co-founder
Profile summary: LEXMA Technology • Co-Founder · PhD at Sapienza Università di Roma

The startup develops a healthcare platform that utilizes WeResp for lung morphology analysis and DigiScan for physiological modeling and AI-driven analytics. This technology enables the simulation of alternative therapies for cardiorespiratory disorders, providing patients with personalized treatment plans based on accurate data.
Raised to date
$6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.